1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of a novel BCL-XL degrader, DT2216, in preclinical models of post-myeloproliferative neoplasm secondary AML
    Meeting Abstract

    Wang, Z.; Skwarska, A.; Poigailwar, G.; Chaudhry, S.; Rodriguez-Meira, A.; Sui, P.; Olivier, E.; Jia, Y.; Ramage, C. L.; Zheng, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Feasibility and implementation of the ASH Research Collaborative's COVID-19 OutcomeS in Myeloma and the Impact of VaCcines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Wood, W. A.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Anderson, K. C.; Kumar, S.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The LMO2-LDB1-TAL1 complex regulates transcription networks in AML relapse
    Meeting Abstract

    Dunham, N.; Wang, Z.; Neelamraju, Y.; Guo, Y.; Hardwick, J.; Maier, B.; Meydan, C.; Gandara, J. A.; Lee, T.; Prajapati, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • TET2 and TP53 mutations cooperate in leukemia development and modulate the response to inflammation
    Meeting Abstract

    Vela, P. S.; Kelly, B.; Brady, C.; Foox, J.; Glass, J.; Levine, R. L.; Shih, A. L.
    Blood (2024)

    Fulltext@MSK | Save
  • Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial
    Meeting Abstract

    Cortes, J. E.; Rea, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M. W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Reduction in platelet counts may predict the development of immune effector cell associated neurotoxicity syndrome in patients receiving CD19 CAR-T cell therapy for relapsed/refractory large B cell lymphoma
    Meeting Abstract

    Khatib, H.; Parizat, A.; Halloun, J.; Shouval, R.; Shibli, N.; Alalouf, O.; Zuckerman, T.; Vahaba, N.; Halamish, I.; Sapir, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Budde, E. L.; Matasar, M.; Sehn, L. H.; Assouline, S. E.; Kuruvilla, J.; Flinn, I. W.; Yoon, S. S.; Bosch, F.; Greenwald, D.; Gutierrez, N. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Leukemiaphysician's perspective on transplant in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Vanegas, Y. A. M.; El Khatib, S. Y. M.; Hisrich, B.; Coltoff, A.; Shallis, R. M.; Patel, A. A.; Bewersdorf, J. P.; Oh, T. S.; Abaza, Y.; Foucar, C.; more...
    Blood (2024)

    Fulltext@MSK | Save